Immunome Inc
IMNM10.300USD
+0.350+3.52%
Close 08/22, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
896.23MMarket Cap
LossP/E TTM
Immunome Inc
10.300
+0.350+3.52%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2019Q4
FY2019Q3
Total revenue
184.35%2.93M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
--3.83M
--3.56M
--4.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
184.35%2.93M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
--3.83M
--3.56M
--4.26M
--2.36M
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
122.52%47.56M
230.01%58.34M
469.97%46.73M
259.32%36.06M
212.71%21.37M
127.01%17.68M
-3.94%8.20M
12.44%10.04M
-41.35%6.83M
-0.73%7.79M
10.50%8.53M
55.51%8.93M
199.05%11.65M
92.59%7.84M
174.06%7.72M
--5.74M
--3.90M
41.03%4.07M
3.60%2.82M
--2.89M
--2.72M
R&D expenses
139.91%36.87M
398.80%47.89M
884.65%37.20M
412.57%29.08M
296.93%15.37M
127.89%9.60M
-27.42%3.78M
-0.75%5.67M
-52.07%3.87M
-3.92%4.21M
15.33%5.21M
76.83%5.72M
308.19%8.08M
138.96%4.38M
174.51%4.51M
--3.23M
--1.98M
-24.55%1.83M
-26.41%1.64M
--2.43M
--2.23M
Depreciation, depletion, and amortization
289.17%611.00K
198.01%450.00K
270.27%411.00K
443.56%549.00K
67.02%157.00K
58.95%151.00K
7.77%111.00K
-10.62%101.00K
-15.32%94.00K
-19.49%95.00K
-63.99%103.00K
-35.43%113.00K
-36.93%111.00K
-53.91%118.00K
61.58%286.00K
--175.00K
--176.00K
59.01%256.00K
14.94%177.00K
--161.00K
--154.00K
Operating profit
-119.40%-44.64M
-301.40%-55.60M
-845.74%-43.82M
-483.70%-33.70M
-355.04%-20.34M
-77.87%-13.85M
45.71%-4.63M
35.32%-5.77M
61.64%-4.47M
0.73%-7.79M
-10.50%-8.53M
-55.51%-8.93M
-199.05%-11.65M
-92.59%-7.84M
-174.06%-7.72M
---5.74M
---3.90M
-41.03%-4.07M
-3.60%-2.82M
---2.89M
---2.72M
Net non-operating interest income (expenses)
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-67.65%11.00K
--10.00K
--34.00K
----
Special income (expenses)
95.53%-5.00M
66.12%-27.37M
---6.71M
---6.31M
---111.95M
---80.80M
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--11.00K
---5.55M
----
--0.00
Other non-operating income (expenses)
--5.00M
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
-100.00%0.00
----
---3.00K
--6.00K
--500.00K
----
----
----
----
----
Income before tax
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
49.08%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
---3.90M
-39.39%-4.07M
-206.07%-8.38M
---2.92M
---2.74M
Income after tax
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
49.08%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
---3.90M
-39.39%-4.07M
-206.07%-8.38M
---2.92M
---2.74M
Net income from continuous operations
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
49.08%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
---3.90M
-39.39%-4.07M
-206.07%-8.38M
---2.92M
---2.74M
Net income attributable to controlling interests
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
52.54%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-18.59%-9.15M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
---3.90M
-39.39%-4.07M
-206.07%-8.38M
---2.92M
---2.74M
Net income attributable to common shareholders
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
52.54%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-18.59%-9.15M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
---3.90M
-39.39%-4.07M
-206.07%-8.38M
---2.92M
---2.74M
Basic earnings per share
79.13%-0.52
41.01%-1.28
-119.70%-0.78
-32.29%-0.60
-616.76%-2.51
-237.21%-2.16
52.83%-0.36
38.09%-0.46
63.54%-0.35
1.01%-0.64
-16.70%-0.75
-60.86%-0.74
-162.40%-0.96
-69.72%-0.65
18.60%-0.65
---0.46
---0.37
-21.39%-0.38
-169.51%-0.79
---0.31
---0.29
Diluted earnings per share
79.13%-0.52
41.01%-1.28
-119.70%-0.78
-32.29%-0.60
-616.76%-2.51
-237.21%-2.16
52.83%-0.36
38.09%-0.46
63.54%-0.35
1.01%-0.64
-16.70%-0.75
-60.86%-0.74
-162.40%-0.96
-69.72%-0.65
18.60%-0.65
---0.46
---0.37
-21.39%-0.38
-169.51%-0.79
---0.31
---0.29
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
